ClinicalTrials.gg
Drug

Scopolamine clinical trials

Also written Hyoscine.

Includes 6 studies of DPI-386.

studies test it
45
open now
4
in phase 3
10
first study started
2003

How each study uses Scopolamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Scopolamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
31 Dec 1979 · TRANSDERM SCOP · NDA 017874 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Scopolamine
24
Kwells
2
Transderm Scop
2
scopolamine patch
2
Scopolamine Hydrobromide
2

Brand

Transderm-Scop
1

Development codes

DPI-386
1

Other names

Hyoscine
3
hyoscine hydrobromide
2

Studies by the year they started

45 studies that test it; most in 2016 (6)

Studies that test Scopolamine, by start year
YearStudies
20031
20041
20051
20061
20081
20091
20102
20111
20132
20144
20152
20166
20174
20183
20196
20201
20213
20223
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
10
Phase 2
13
Phase 3
10
Phase 4
8
No phase
6

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 28

Repurposed Therapeutics, Inc. (11) · Medical Corps, Israel Defense Force (2) · National Institute of Mental Health (NIMH) (2) · Massachusetts General Hospital (2) · Dartmouth-Hitchcock Medical Center (1) · Dr. Brian Hallahan (1) · Stony Brook University (1) · Rutgers, The State University of New Jersey (1)

Often tested with

Tested in the same studies.

Propofol (3) · Ketamine (3) · Meclizine (2) · Aprepitant (2) · Dexmedetomidine (2) · Fentanyl (2) · Sevoflurane (2) · Desflurane (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Scopolamine.

Studies

Open first, then newest update. How each study uses Scopolamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 45

See all 45 studies that test Scopolamine →

Given beside what is tested · 4 — Scopolamine is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Scopolamine

Codes

What other systems call Scopolamine · ClinicalTrials.gg INT008184

  • MeSH (NLM) D012601ScopolamineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) DL48G20X8XSCOPOLAMINEConfirmed FDA, NLM, Wikidata
  • RxNorm 9601Confirmed FDA, Wikidata
  • Wikidata Q337188L-scopolamineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C47712ScopolamineOne source FDA
  • DrugBank DB00747One source Wikidata

Also registered as scopolamine hydrobromide (UNII 451IFR0GXB · RxNorm 9603).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.